| 000 | 01865 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514181252.0 | ||
| 264 | 0 | _c20050111 | |
| 008 | 200501s 0 0 eng d | ||
| 022 | _a1619-7070 | ||
| 024 | 7 |
_a10.1007/s00259-004-1479-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSoerdjbalie-Maikoe, Vidija | |
| 245 | 0 | 0 |
_aBone scintigraphy predicts the risk of spinal cord compression in hormone-refractory prostate cancer. _h[electronic resource] |
| 260 |
_bEuropean journal of nuclear medicine and molecular imaging _cJul 2004 |
||
| 300 |
_a958-63 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Neoplasms _xblood |
| 650 | 0 | 4 |
_aCervical Vertebrae _xdiagnostic imaging |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aLumbar Vertebrae _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNetherlands _xepidemiology |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
| 650 | 0 | 4 | _aRadionuclide Imaging |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSpinal Cord Compression _xblood |
| 650 | 0 | 4 |
_aThoracic Vertebrae _xdiagnostic imaging |
| 700 | 1 | _aPelger, Rob C M | |
| 700 | 1 | _aLycklama à Nijeholt, Guus A B | |
| 700 | 1 | _aArndt, Jan-Willem | |
| 700 | 1 | _aZwinderman, Aeilko H | |
| 700 | 1 | _aBril, Herman | |
| 700 | 1 | _aPapapoulos, Socrates E | |
| 700 | 1 | _aHamdy, Neveen A T | |
| 773 | 0 |
_tEuropean journal of nuclear medicine and molecular imaging _gvol. 31 _gno. 7 _gp. 958-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00259-004-1479-z _zAvailable from publisher's website |
| 999 |
_c14706998 _d14706998 |
||